| |
 |
| |
|
|
Watson Bio is a private corporation enterprise, which possesses one international invention patent and one patent technology, and both have independent intellectual property rights. The international invention patent is on the technique of “ultramicroparticle using nanometer technology for traditional Chinese medicines and health-care products”, while the patent technology is the “high-flux genetic testing and analyzing system”. Both these two accomplishments resulted from the fact that Watson Bio has been attaching great importance to the development and advancement of technology, and this is also the core feature that distinguishes Watson Bio from the other biological medicines preparation enterprises.
The patent technology has enabled Watson Bio to multiple the utilization rate of raw medicine materials in extracting and processing of the TCM, and also could be employed to greatly improve the curative effect of the medical preparation when the company enters the field of biological preparation in the future; this patent technology is applied from the beginning to the end in the whole production process, which includes planting, extracting and processing, and it also controls effectively the quality and the healthy plants rate of the plants as raw materials for both TCM and TAXOL. |
| |
|
|
